Summary
Crystallographic database studies and molecular dynamics simulations in different media have enabled us to sample the conformational space of a GABAB antagonist. As a result, we have defined a pharmacophoric pattern for GABAB antagonists. This study has led us to compare the conformational preferences deduced from database studies and molecular dynamics simulations. The influence of the medium on the conformations has also been investigated.
Similar content being viewed by others
References
Krogsgaard-Larsen, P., Frølund, B., Jørgensen, F.S. and Schousboe, A., J. Med. Chem., 37 (1994) 2489.
Bowery, N.G., Annu. Rev. Pharmacol. Toxicol., 33 (1993) 109.
Chapman, R.W., Hey, J.A., Rizzo, C.A. and Bolser, D.C., Trends Pharmacol. Sci., 14 (1993) 26.
Bittiger, H., Froestl, W., Mickel, S.J. and Olpe, H.R., Trends Pharmacol. Sci., 14 (1993) 391.
Berthelot, P., Vaccher, C., Musadad, A., Flouquet, N., Debaert, M. and Luyckx, M., J. Med. Chem., 30 (1987) 743.
Berthelot, P., Vaccher, C., Flouquet, N., Debaert, M., Luyckx, M. and Brunet, C., J. Med. Chem., 34 (1991) 2557.
Hammond, D.L. and Moy, M.L., Eur. J. Pharmacol., 229 (1992) 227.
Kerr, D.I.B., Ong, J., Johnston, G.A.R., Berthelot, P., Debaert, M. and Vaccher, C., Eur. J. Pharmacol., 164 (1989) 361.
Ong, J., Kerr, D.I.B., Berthelot, P., Vaccher, C., Flouquet, N. and Debaert, M., Eur. J. Pharmacol., 221 (1992) 145.
Pirard, B., Paquet, B., Evrard, G., Berthelot, P., Vaccher, C., Ansard, M.H., Debaert, M. and Durant, F., Eur. J. Med. Chem., 30 (1995) 851.
Froestl, W., Mickel, S.J., Von, Sprecher, G., Bittiger, H. and Olpe, H.R., Pharmacol. Commun., 2 (1992) 52.
Leach, A.R., In Lipkowitz, K.B. and Boyd, D.B. (Eds.) Reviews in Computational Chemistry, Vol. 2, VCH, New York, NY, 1991, pp. 1–55.
Allen, F.H. and Kennard, O., CDA News, 8 (1993) 31.
Allen, F.H., Johnson, O., Macrae, C.F., Smith, M.J., Motherwell, S.W.D., Galloy, J.J., Watson, D.G., Rowland, R.S., Edgington, P.R., Garner, S.E., Davies, J.E. and Mitchell, G.F., CSD System, Vol. 1, Cambridge Crystallographic Data Centre, Cambridge, 1992, pp. 639–645.
Willett, P., In Dean, P.M. (Ed.) Molecular Similarity in Drug Design, Blackie Academic & Professional, London, 1995, pp. 110–132.
Willett, P., Winterman, V. and Bawden, D., J. Chem. Inf. Comput. Sci., 26 (1986) 36.
Vanderveken, D.J. and Vercauteren, D.P., ZEDIT, Facultés Universitaires Notre-Dame de la Paix, Namur, 1992.
Auffinger, P. and Wipff, G., J. Comput. Chem., 11 (1990) 19.
Rekker, R.F. and Mannhold, R., Calculation of Drug Lipophilicity: The hydrophobic Fragmental Constant Approach, VCH, Weinheim, 1992.
DISCOVER, v. 2.9.5/94.0, Biosym Technologies, San Diego, CA, 1994.
DISCOVER, v. 2.9.5/94.0, User Guide, Part 1, Biosym Technologies, San Diego, CA, 1994, pp 3.1–3.32.
Maple, J.R., Hwang, M.-J., Stockfisch, T.P., Dinur, U., Waldman, M., Ewig, C.S. and Hagler, A.T., J. Comput. Chem., 15 (1994) 162.
Maple, J.R., Dinur, U. and Hagler, T., Proc. Natl. Acad. Sci. USA, 85 (1988) 5350.
Perez, J.J., Villar, H.O. and Loew, G.H., J. Comput.-Aided Mol. Design, 6 (1992) 175.
INSIGHT II, v. 2.3.0, Biosym Technologies, San Diego, CA, 1993.
Coluci, W.J., Gandour, R.D. and Mooberry, E.A., J. Am. Chem. Soc., 108 (1986) 7147.
Vaccher, C., Berthelot, P., Flouquet, N., Marko, J. and Debaert, M., Spectrochim. Acta, 47 (1991) 1071.
Vaccher, C., Berthelot, P., Debaert, M., Vermeersch, G., Guyon, R., Pirard, B., Vercauteren, D.P., Dory, M., Evrard, G. and Durant, F., J. Mol. Struct., 301 (1993) 199.
Böhm, H.J., Klebe, G., Lorenz, T., Mietzner, T. and Siggel, L., J. Comput. Chem., 11 (1990) 1021.
Falch, E., Hedegaard, A., Nielsen, L., Jensen, B.R., Hjeds, H. and Krogsgaard-Larsen, P., J. Neurochem., 47 (1986) 898.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pirard, B., Durant, F. Molecular modelling and conformational analysis of a GABAB antagonist. J Computer-Aided Mol Des 10, 31–40 (1996). https://doi.org/10.1007/BF00124463
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00124463